Automatic summarization of risk factors preceding disease progression an insight-driven healthcare service case study on using medical records of diabetic patients
- 139 Downloads
In this study we consider the problem of how to derive insight from medical records to define and improve healthcare services. As noted in many guidelines, risk factors are important to determining the care plan of chronic disease patients, e.g., pre-diabetic or diabetic patients who have started on hemoglobin A1c (HbA1c) control medications. Whereas the traditional management of chronic disease relies on a predetermined set of risk factors, without regard to patient-specific status, literature and recently released guidelines have suggested a less-prescriptive approach that allows flexibility in disease management plans to account for patient-centric information shown in medical records. However, methods of systematically summarizing medical records into risk factors have not been evaluated to support such a patient-centric focus in healthcare services. In this study, we evaluated automatic methods that can identify risk factors important for classifying Diabetic patients at risk of worsen disease progression. In particular, we used the prescription of cardiovascular disease (CVD) medication as the indicator of CVD co-morbidity development in Diabetic patients. We evaluated the summaries obtained with different sources of health information on the risk stratification task and examined the quality of the generated summaries using various proposed intrinsic metrics. In addition, we evaluated to what extent we can reduce the whole medical records into a small set of risk factors. The evaluation illustrates the potential of risk factor summarization and hints on how it can be used to enable practitioners in care planning and to support complex follow-up services at both the point of care and the extended care settings.
KeywordsHealthcare service design Case study Disease management Data-driven analytics Medical record summarization
Unable to display preview. Download preview PDF.
- 5.Cairncross, J.G., Ueki, K., Zlatescu, M.C., Lisle, D.K., Finkelstein, D.M., Hammond, R.R., Silver, J.S., Stark, P.C., Macdonald, D.R., Ino, Y., Ramsay, D.A., Louis, D.N.: Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients with Anaplastic Oligodendrogliomas. J. Natl. Cancer Inst. 90(19), 1473–9 (1998)CrossRefGoogle Scholar
- 6.Carr VL, Sangiorgi D, Büscher M, Junginger S, Cooper R. Integrating evidence-based design and experience-based approaches in healthcare service design. HERD. 2011 Summer; 4 (4):12–33Google Scholar
- 8.Concaro S, Sacchi L, Cerra C, Stefanelli M. Temporal Data Mining for the Assessment of the Costs Related to Diabetes Mellitus Pharmacological Treatment. Proc. AMIA 2009 Symposium Proceedings 2009; 119–123.Google Scholar
- 10.de Ruijter, W., Westendorp, R.G.J., Assendelft, W.J.J., den Elzen, W.P.J., de Craen, A.J.M., le Cessie, S., Gussekloo, J.: Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 338(7688), a3083 (2008)Google Scholar
- 11.Genest, J., Libby, P.: Lipoprotein disorders and cardiovascular disease. In: Bonow, R.O., Mann, D.L., Zipes, D.P., Libby, P. (eds.) Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 9th edn. Elsevier, Philadelphia (2011). chap 47Google Scholar
- 12.Henry N. Ginsberg. the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial: What we learn from subgroup analyses. Diabetes Care May 2011; 34 (2): 107–108.Google Scholar
- 13.Inzucchi, S.E., Bergenstal, R.M., Buse, J.B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A.L., Tsapas, A., Wender, R., Matthews, D.R.: Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35(6), 1364–79 (2012)CrossRefGoogle Scholar
- 15.Klausen, K., Borch-Johnsen, K., Feldt-Rasmussen, B., Jensen, G., Clausen, P., Scharling, H., Appleyard, M., Jensen, J.S.: Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes. Circulation 110(1), 32–5 (2004)CrossRefGoogle Scholar
- 17.Lindstrom J. and Tuomilehto J. The Diabetes Risk Score: A practical tool to predict type 2 diabetes risk Diabetes Care 2003; 26:3: 725–731.Google Scholar
- 22.Victor, R.G.: Arterial hypertension. In: Goldman, L., Schafer, A.I. (eds.) Cecil Medicine, 24th edn. Elsevier, Philadelphia (2011). chap 67Google Scholar